Edge Pharma, LLC recalls Methotrexate, USP Sterile Solution for Injection, Preservative Free 125mg/5ml (25mg/ml), 5 mL per syringe, Rx Only, SYRI
Recalled January 20, 2021 · FDA recall D-0226-2021 · Edge Pharma
Hazard
Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired. · FDA Class II
Units
71 syringes
Sold at
Nationwide
Description
Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.
Product
Methotrexate, USP Sterile Solution for Injection, Preservative Free 125mg/5ml (25mg/ml), 5 mL per syringe, Rx Only, SYRINGE FOR IM INJECTION, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178, Barcode 0544650505
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →